To test the method sensitivity in the detection of mutated clones, we took advantage of the AML cell lines MOLM-13 (harbouring a heterozygous ITD mutation) and OCI-AML3 (expressing wild-type FLT3). This evidence concerns the gene FLT3 and acute myeloid leukemia.